Use of ceftolozane/tazobactam as salvage therapy for infections due to extensively drug-resistant Pseudomonas aeruginosa.
Dinh A, Wyplosz B, Kernéis S, Lebeaux D, Bouchand F, Duran C, Béraud G, Lazaro P, Davido B, Hénard S, Canouï E, Ferry T, Wolff M.
Dinh A, et al. Among authors: duran c.
Int J Antimicrob Agents. 2017 Jun;49(6):782-783. doi: 10.1016/j.ijantimicag.2017.04.001. Epub 2017 Apr 12.
Int J Antimicrob Agents. 2017.
PMID: 28412272
No abstract available.